Publication Date:
1978-01-20
Description:
Application of information derived from a three-dimensional model of vasopressin bound to its antidiuretic receptor has resulted in the design and synthesis of a potent analog, [1-deamino, 2-phenylalanine, 7-(3,4-dehydroproline)]-arginine vasopressin; this analog has a specific antidiuretic activity of 13,000 +/- 1,250 units per milligram; noteworthy at these doses is the absence of any detectable pressor activity. Three modifications based on conformational considerations were introduced into the vasopressin molecule in preparing the analog: (i) to enhance binding, a double bond was introduced into the side chain of an amino acid residue occupying a corner position of a beta turn in the vasopressin conformation, (ii) the hydroxyl moiety was deleted from Tyr2, and (iii) to tighten the backbone structure and to enhance the enzymatic resistance of the analog, the NH2-terminal amino group was deleted.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Smith, C W -- Walter, R -- New York, N.Y. -- Science. 1978 Jan 20;199(4326):297-9.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/619455" target="_blank"〉PubMed〈/a〉
Keywords:
Amino Acid Sequence
;
Deamino Arginine Vasopressin/analogs & derivatives
;
Diuresis/drug effects
;
Heart Rate/drug effects
;
Protein Conformation
;
Structure-Activity Relationship
;
Vasopressins/*analogs & derivatives/pharmacology
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
